{"celex_id": "31995D0471", "uri": "http://publications.europa.eu/resource/cellar/8e8cd698-a70b-4676-a9ff-9aad7d0a84d1", "type": "Decision", "concepts": ["1598", "4281", "4291", "4635", "994"], "title": "95/471/EC: Commission Decision of 26 October 1995 amending Decision 93/590/EC for the purchase by the Community of foot-and-mouth disease antigens within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines\n", "header": "COMMISSION DECISION of 26 October 1995 amending Decision 93/590/EC for the purchase by  the Community of foot-and-mouth disease antigens within the framework of the Community action  concerning reserves of foot-and-mouth disease vaccines (Text with EEA relevance) (95/471/EC)\nTHE COMMISSION OF THE EUROPEAN COMMUNITIES", "recitals": ",\nHaving regard to the Treaty establishing the European Community,\nHaving regard to Council Decision 91/666/EEC of 11 December 1991 eatablishing Community reserves of  foot-and-mouth disease vaccines  (1), and, in particular Article 7 thereof,\nWhereas Commission Decision 93/590/EC of 5 November 1993, for the purchase of foot-and-mouth  disease antigens within the framework of the Community action concerning reserves of foot-and-mouth  disease vaccines  (2), makes provisions for the antigen to be stored at four locations;\nWhereas the operators of the antigen bank located in the premises of Bayer, Cologne, have informed  the Commission that they no longer wish to provide this service to the Community;\nWhereas, therefore, it is necessary to make provisions to transfer the antigen stored at Cologne to  another bank;\nWhereas the measures provided for in this Decision are in accordance with the opinion of the  Standing Veterinary Committee,", "main_body": ["Article 3 of Decision 93/590/EC is replaced by the following:\n'Article 3 The antigen shall be divided between the three antigen banks as follows:   (a)  The Institute for Animal Health, Pirbright: 2,5 million doses of each of O1 European Strain  and A5 European strain;\n(b)  lZP, Brescia: 2,5 million doses of each of O1 Middle East strain and A22;\n(c)  LNPB, Lyon: 2,5 million doses of each of O1 Middle East strain, A22, O1 European strain and  A5, O1 European strain.`", "This Decision is addressed to the Member States."], "attachments": "Done at Brussels, 26 October 1995.\nFor the Commission Franz FISCHLER Member of the Commission"}